Post-approval studies (Phase 4)Study completedNCT02034747
What this trial is testing
Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
Who this might be right for
Kidney Transplant
Astellas Pharma Korea, Inc. 150